BEACON introduced another promising multiple Tyrosine kinase inhibitor, Cabozanitib, under the brand name of Cabozanix for global market.
Cabozanitibis an anticancer drug for:
- Renal Cell Carcinoma
- Metastatic Thyroid Cancer
Cabozanix is an oral Capsule preparation which is available in the strengths of 20 mg &80mg. Each pack Cabozanix 20 contains 90 capsules and Cabozanix 80 contains30 capsules per HDPE pot. This product is only for export.